Skip to content

The Effectiveness of Transdiagnostic Cognitive-Behavioral Therapy Protocol on Subclinical Symptoms of Anxiety and Depression, Emotion Regulation, Resilience and Spiritual Health

The Effectiveness of Transdiagnostic Cognitive-Behavioral Therapy Protocol on Reducing Subclinical Symptoms of Anxiety and Depression, Improving Emotion Regulation, Resilience and Spiritual Health in Students

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211223053494N4
Enrollment
56
Registered
2023-05-11
Start date
2023-05-31
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Emotion Regulation, Resilience and Spiritual Health. Psychological and behavioral factors associated with disorders or diseases classified elsewhere

Interventions

Intervention 1: Intervention group: includes all students of Farhangian University of Tehran province who receive integrated transdiagnostic treatment as a group according to the protocol in 14 sessio

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: having preclinical anxiety and depression symptoms based on the cut-off point of a score of 18 and above in the DASS-42 subscale and a score of 16 and above in the anxiety subscale of the DASS-42 scale, Not suffering from specific or underlying physical diseases, Not suffering from severe psychiatric disorders such as bipolar spectrum disorders, psychotic spectrum disorders, and cognitive disorders. Not using drugs and alcohol in the last three months. Absence of speech or hearing problems Willingness to participate in research

Exclusion criteria

Exclusion criteria: absence of more than two sessions, receiving another similar psychological intervention at the same time as the current research, receiving cognitive-behavioral interventions for at least 8 sessions in the last 1 year, receiving psychiatric drugs at the same time as the intervention or within a month before the intervention, Lack of consent to continue the treatment during the intervention process, Aggravation of the person's problems during the intervention and the need to provide another intervention

Design outcomes

Primary

MeasureTime frame
Cognitive Emotion Regulation Score (CERQ) in the Garnevsky Questionnaire, Craig Vaspinhaven. Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Cognitive Emotion Regulation Questionnaire (CERQ).;Depression, anxiety and stress score in Lovibond and Lovibond scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Depression- Anxiety- Stress Scale (DASS).

Secondary

MeasureTime frame
Spiritual well-being score in Paloutzian and Ellison questionnaire. Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Spiritual well-being (SWB).;Cognitive flexibility score in Dennis scale. Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Cognitive flexibility scale (CFI).;Connor and Davidson Resilience Scale (CD-RISC). Timepoint: At the beginning of the study (before the intervention), after the intervention and 2 months after the intervention. Method of measurement: Connor and Davidson Resilience Scale (CD-RISC).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Elnaz Mousavi

Zanjan University of Medical Sciences

Dr.Emousavi@zums.ac.ir+98 24 3353 4500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026